PD-L1 assessment in lung cancer biopsies—pitfalls and limitations

The programmed cell death-ligand 1 (PD-L1) protein expression on tumor cells predicts the efficacy of immunotherapy in patients with non-small cell lung cancer. However, the assessment of PD-L1 expression on tumor cells has limited power for selecting patients for immunotherapy due to intra-tumoral...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The International Journal of Biological Markers 2024-03, Vol.39 (1), p.3-8
Hauptverfasser:	Gompelmann, Daniela, Sarova, Pavla, Mosleh, Berta, Papaporfyriou, Anastasia, Oberndorfer, Felicitas, Idzko, Marco, Hoda, Mir Alireza
Format:	Artikel
Sprache:	eng
Schlagworte:	Apoptosis Biomarkers Biopsy Cell death Immunotherapy Lung cancer Non-small cell lung carcinoma PD-L1 protein Small cell lung carcinoma Tumor cells Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!